Abcellera Biologicsinc Stock Price Prediction
| ABCL Stock | USD 3.97 0.04 1.00% |
Oversold Vs Overbought
52
Oversold | Overbought |
Abcellera BiologicsInc stock price prediction is an act of determining the future value of Abcellera BiologicsInc shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Abcellera BiologicsInc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Abcellera BiologicsInc and does not consider all of the tangible or intangible factors available from Abcellera BiologicsInc's fundamental data. We analyze noise-free headlines and recent hype associated with Abcellera BiologicsInc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Abcellera BiologicsInc's stock price prediction:Quarterly Earnings Growth 0.459 | EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.64) | EPS Estimate Next Year (0.69) | Wall Street Target Price 15.38 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Abcellera BiologicsInc based on different types of headlines from major news networks to social media. The Abcellera stock price prediction module provides an analysis of price elasticity to changes in media outlook on Abcellera BiologicsInc over a specific investment horizon. Using Abcellera BiologicsInc hype-based prediction, you can estimate the value of Abcellera BiologicsInc from the perspective of Abcellera BiologicsInc response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Abcellera BiologicsInc using Abcellera BiologicsInc's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Abcellera using crowd psychology based on the activity and movement of Abcellera BiologicsInc's stock price.
Abcellera BiologicsInc Short Interest
A significant increase or decrease in Abcellera BiologicsInc's short interest from the previous month could be a good indicator of investor sentiment towards Abcellera. Short interest can provide insight into the potential direction of Abcellera BiologicsInc stock and how bullish or bearish investors feel about the market overall. An investor who is long Abcellera BiologicsInc may also wish to track short interest. As short interest increases, investors should be becoming more worried about Abcellera BiologicsInc and may potentially protect profits, hedge Abcellera BiologicsInc with its derivative instruments, or be ready for some potential downside.
200 Day MA 5.1762 | Short Percent 0.1118 | Short Ratio 17.89 | Shares Short Prior Month 23 M | 50 Day MA 4.6892 |
Abcellera BiologicsInc Hype to Price Pattern
Investor biases related to Abcellera BiologicsInc's public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera BiologicsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Abcellera BiologicsInc's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Abcellera BiologicsInc.
Abcellera BiologicsInc Implied Volatility | 74.8 |
Abcellera BiologicsInc's implied volatility exposes the market's sentiment of Abcellera BiologicsInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abcellera BiologicsInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abcellera BiologicsInc stock will not fluctuate a lot when Abcellera BiologicsInc's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Abcellera BiologicsInc. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Abcellera BiologicsInc to buy its stock at a price that has no basis in reality. In that case, they are not buying Abcellera because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Abcellera BiologicsInc after-hype prediction price | USD 4.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Abcellera |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcellera BiologicsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abcellera BiologicsInc After-Hype Price Prediction Density Analysis
As far as predicting the price of Abcellera BiologicsInc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Abcellera BiologicsInc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Abcellera BiologicsInc, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Abcellera BiologicsInc Estimiated After-Hype Price Volatility
In the context of predicting Abcellera BiologicsInc's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Abcellera BiologicsInc's historical news coverage. Abcellera BiologicsInc's after-hype downside and upside margins for the prediction period are 0.81 and 7.19, respectively. We have considered Abcellera BiologicsInc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Abcellera BiologicsInc is somewhat reliable at this time. Analysis and calculation of next after-hype price of Abcellera BiologicsInc is based on 3 months time horizon.
Abcellera BiologicsInc Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Abcellera BiologicsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abcellera BiologicsInc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Abcellera BiologicsInc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 3.19 | 0.03 | 1.00 | 8 Events / Month | 9 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.97 | 4.00 | 0.76 |
|
Abcellera BiologicsInc Hype Timeline
Abcellera BiologicsInc is presently traded for 3.97. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -1.0. Abcellera is forecasted to increase in value after the next headline, with the price projected to jump to 4.0 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 0.76%, whereas the daily expected return is presently at -0.42%. The volatility of related hype on Abcellera BiologicsInc is about 133.47%, with the expected price after the next announcement by competition of 2.97. The company reported the previous year's revenue of 38.02 M. Net Loss for the year was (146.4 M) with profit before overhead, payroll, taxes, and interest of 311.11 M. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Abcellera BiologicsInc Basic Forecasting Models to cross-verify your projections.Abcellera BiologicsInc Related Hype Analysis
Having access to credible news sources related to Abcellera BiologicsInc's direct competition is more important than ever and may enhance your ability to predict Abcellera BiologicsInc's future price movements. Getting to know how Abcellera BiologicsInc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Abcellera BiologicsInc may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CWBR | CohBar Inc | 0.02 | 2 per month | 0.00 | (0.24) | 6.67 | (10.89) | 60.37 | |
| HEPA | Hepion Pharmaceuticals | 0.03 | 7 per month | 0.00 | (0.05) | 11.79 | (10.73) | 48.29 | |
| RAIN | Rain Therapeutics | 0.00 | 8 per month | 1.78 | 0.06 | 4.76 | (3.45) | 9.93 | |
| KRYS | Krystal Biotech | (7.19) | 12 per month | 2.42 | 0.06 | 5.24 | (4.31) | 45.71 | |
| AVRO | AVROBIO | 0.02 | 5 per month | 0.00 | (0.08) | 3.03 | (3.17) | 19.09 | |
| CVAC | CureVac NV | (0.03) | 8 per month | 0.00 | (0.22) | 3.74 | (5.06) | 13.61 | |
| RETA | Reata Pharmaceuticals | (0.25) | 7 per month | 0.38 | 0.14 | 3.54 | (2.91) | 54.98 | |
| VIR | Vir Biotechnology | (0.14) | 8 per month | 0.00 | (0.09) | 4.84 | (5.69) | 18.31 | |
| PPCB | Propanc Biopharma | 0.00 | 0 per month | 0.00 | (0.13) | 29.41 | (27.50) | 77.42 | |
| PTCT | PTC Therapeutics | 1.26 | 9 per month | 0.00 | (0.03) | 4.89 | (5.68) | 19.51 | |
| SRPT | Sarepta Therapeutics | (1.58) | 9 per month | 1.97 | (0.03) | 3.23 | (2.85) | 14.76 | |
| IOVA | Iovance Biotherapeutics | 0.32 | 12 per month | 3.40 | 0.1 | 8.39 | (6.29) | 40.20 | |
| MDGL | Madrigal Pharmaceuticals | (23.53) | 9 per month | 4.46 | (0.01) | 8.89 | (7.09) | 24.70 |
Abcellera BiologicsInc Additional Predictive Modules
Most predictive techniques to examine Abcellera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Abcellera using various technical indicators. When you analyze Abcellera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Abcellera BiologicsInc Predictive Indicators
The successful prediction of Abcellera BiologicsInc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Abcellera BiologicsInc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Abcellera BiologicsInc based on analysis of Abcellera BiologicsInc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Abcellera BiologicsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Abcellera BiologicsInc's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 156.21 | 29.02 | 618.0 | 648.9 | PTB Ratio | 3.84 | 2.34 | 1.43 | 1.36 |
Story Coverage note for Abcellera BiologicsInc
The number of cover stories for Abcellera BiologicsInc depends on current market conditions and Abcellera BiologicsInc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Abcellera BiologicsInc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Abcellera BiologicsInc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Abcellera BiologicsInc Short Properties
Abcellera BiologicsInc's future price predictability will typically decrease when Abcellera BiologicsInc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Abcellera BiologicsInc often depends not only on the future outlook of the potential Abcellera BiologicsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abcellera BiologicsInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 289.2 M | |
| Cash And Short Term Investments | 760.6 M |
Check out Abcellera BiologicsInc Basic Forecasting Models to cross-verify your projections. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.